AGTR1 and neoplasm: In another work, candesartan was used as both a drug and a targeting molecule as it has a strong affinity and inhibition ability for the angiotensin II type-1 receptor (AT1R) expressed on the surface of neovascular endothelial cells and many tumor cells [173].